Bausch Health Files 8-K on Financials
Ticker: BHC · Form: 8-K · Filed: Feb 19, 2025 · CIK: 885590
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Bausch Health dropped an 8-K on Feb 19th detailing their financials. Check it out.
AI Summary
Bausch Health Companies Inc. filed an 8-K on February 19, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Laval, Quebec, Canada.
Why It Matters
This filing provides investors with crucial updates on Bausch Health's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant events.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- February 19, 2025 (date) — Filing Date
- Laval, Quebec, Canada (location) — Principal Executive Offices
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Bausch Health Companies Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on February 19, 2025.
Where are Bausch Health Companies Inc.'s principal executive offices located?
Bausch Health Companies Inc.'s principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
What is the Standard Industrial Classification code for Bausch Health Companies Inc.?
The Standard Industrial Classification code for Bausch Health Companies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What were some of Bausch Health's previous company names?
Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 19, 2025 regarding Bausch Health Companies Inc. (BHC).